Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
PPP1R27 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
GGNBP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SEMA6D - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LZTFL1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PLXNB3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RAD51 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SERF1B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LYG1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PKNOX2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC100287015 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
H1FNT - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
UPB1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SIRT5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NEDD4L - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MFF - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ABLIM2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LYPD6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on